Inhibrx Biosciences, Inc. (Nasdaq: INBX) (Inhibrx or the Company) today reported financial results for the third quarter of 2026. The biopharmaceutical company has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results